NSV Partners III GP LLC, 10% Owner at Ventyx Biosciences, Inc. (VTYX), sold 63,842 shares at $37.54 ($2.4M) on 2023-07-11, disclosed to the SEC on 2023-07-13.
Scheduled sale ($2.4M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.54 | 28,646 | $1.1M | 44.9% |
| 2 | $37.54 | 28,646 | $1.1M | 44.9% |
| 3 | $37.62 | 3,275 | $123K | 5.1% |
| 4 | $37.62 | 3,275 | $123K | 5.1% |
| Total | $37.55 avg | 63,842 | $2.4M | 100% |
| Filing → |